90Yttrium ibritumomab tiuxetan (Zevalin) combined with BEAM (Z-BEAM) conditioning regimen plus autologous stem cell transplantation in relapsed or refractory. follicular lymphoma. GELA phase II study

Gisselbrecht, Christian; Decaudin, Didier; Mounier, Nicolas; Tilly, Herve; Ribrag, Vincent; Sebban, Catherine; Milpied, Noel; Morschhauser, Franck; Coiffier, Bertrand; Le Gouill, Steven; Lederlin, Pierre; Delarue, Richard; Laurent, Guy; Bosly, André

90Yttrium ibritumomab tiuxetan (Zevalin) combined with BEAM (Z-BEAM) conditioning regimen plus autologous stem cell transplantation in relapsed or refractory. follicular lymphoma. GELA phase II study

Gisselbrecht, Christian

;

Decaudin, Didier

;

Mounier, Nicolas

;

Tilly, Herve

;

Bosly, André

;et.al.

(2007) 49th Annual Meeting of the American-Society-of-Hematology — Location: Atlanta(Ga) (8.December.2007)

Files

No attached file found for this publication.

Details

Authors

Gisselbrecht, Christian
Author
Decaudin, Didier
Author
Mounier, Nicolas
Author
Tilly, Herve
Author
Bosly, AndréUCLouvain
Author

Affiliations

UCLouvainAutre

Citations

APA
Chicago
FWB

Gisselbrecht, C., Decaudin, D., Mounier, N., Tilly, H., Ribrag, V., Sebban, C., Milpied, N., Morschhauser, F., Coiffier, B., Le Gouill, S., Lederlin, P., Delarue, R., Laurent, G., & Bosly, A. (2007). 90Yttrium ibritumomab tiuxetan (Zevalin) combined with BEAM (Z-BEAM) conditioning regimen plus autologous stem cell transplantation in relapsed or refractory. follicular lymphoma. GELA phase II study. Blood, 110(11), 14A-15A. https://hdl.handle.net/2078.5/148123 (Original work published 2007)